|Publication number||US3912450 A|
|Publication date||Oct 14, 1975|
|Filing date||May 17, 1973|
|Priority date||Jun 21, 1971|
|Publication number||US 3912450 A, US 3912450A, US-A-3912450, US3912450 A, US3912450A|
|Inventors||Raymond Marcel Gut Boucher|
|Original Assignee||Wave Energy Systems|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (7), Referenced by (82), Classifications (24)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent 1 Boucher METHOD FOR SYNERGISTIC DISINFECTION OR STERILIZATION  Inventor:
 Assignee: Wave Energy Systems, Inc., New
' York, N.Y.
 Filed: May 17, 1973 211 Appl. No.: 361,148
Related US. Application Data  Division of Ser. No. 155,233, June 21, 1971.
 US. Cl 21/54 A; 21/54 R; 21/58; 424/333; 424/343; 424/339  Int. Cl. A611 13/00; A611 1/00  Field of Search.. 21/54 R, 54 A, 102 R, 102 A, 21/58; 424/333, 127
Raymond Marcel Gut Boucher, New
FOREIGN PATENTS OR APPLICATIONS 947,699 1/1964 United Kingdom...' 21 /54 R OTHER PUBLICATIONS Sidewell et al.; Potentially Infectious...Bed Pads; Applied Microbiology; Vol. 19; No. 1; Jan. 1970; pp. 53-59.
Borick et al., Alkalimized Glutaraldehyde, A New Antimicrobial Agent, .1. of Pharmaceutical Sciences, Vol. 53, No. 10, 10-64, pp. 1273-1275.
I Primary ExaminerBarry S. Richman Attorney, Agent, or F irm-Shoemaker and Mattare  ABSTRACT A method for disinfecting or sterilizing medical, surgical, dental instruments or other objects in liquid phase with improved sporicidal compositions. The method is based upon the synergistic effects observed when combining nonionic and anionic surfactants with aqueous or alcoholic glutaraldehyde solutions. The method can be used also with ultrasonic irradiation over a wide frequency range (10 to 850 kHz). Two types of particularly effective synergistic sporicidal compositions are also described.
7 Claims, No Drawings METHOD FOR SYNERGISTIC DISINFECTION OR STERILIZATION This is a division of application Ser. No. 155,233 filed June 21,1971.
BACKGROUND OF THE INVENTION This invention relates to a method for disinfecting or sterilizing objects in liquid phase with improved chemosterilizer compositions. The method object of our invention is based upon the synergistic sporicidal effects observed when using relatively moderate temperatures combined or not combined with ultrasonic irradiation in specially formulated sporicidal compositions. The latter are based upon active combinations of glutaraldehyde with nonionic surfactants such as ethoxylates'or isomeric linear alcohols (C to C or anionic alkyl aryl sulfonates.
Through a proper choice of temperatures, acoustic energy density and chemical composition the method object of the present invention enables reducing from hours to minutes the time requirements for surface disinfection or sterilization of heat sensitive materials.
Low temperature surface sterilization in liquid phase has been limited in the past to the use of two chemosterilizer agents: formaldehyde and alkaline glutaraldehyde solutions. This limited choice indeed contrasts with the large number of chemical bactericides available (Quartemary Ammonium compounds, chlorine containing compounds, lodophores, Amphoteric compounds, etc.) when one does not require sporicidal action.
Formaldehyde isone of the oldest chemosterilizers employed for the destruction of spores, and, although 1 percent to 2 percent solutions have been used, a relatively long period of time (up to hours) is required to destroy Bacillus subtilis var. niger spores. A somewhat shorter time is needed if one uses higher concentrations of formaldehyde (around 8 percent) in isopropyl alcohol. This solution, called Formalin has several drawbacks. The irritating fumes of formaldehyde limit its usefulness, and its toxicity for tissue requires that disinfected materials be thoroughly rinsed with sterile water before use.
Alkalanized glutaraldehyde solutions known commercially under the trade name CIDEX are the only widely used for practical applications today. They consist of a 2 percent aqueous glutaraldehyde solution buffered by suitable alkalinating agents (generally 0.3 percent sodium bicarbonate) to pH of 7.5 to 8.5. In the acid state at room temperature the glutaraldehyde solution is stable for long periods of time when stored in a closed container. However, when rendered alkaline, the glutaraldehyde gradually undergoes polymerization and loses its activity. Above pH 9 the polymerization proceeds very rapidly. In the 7.5 to 8.5 pH range polymerization is slower, but it is acknowledged by the manufacturer himself that sporicidal activity disappears after 2 weeks. (ARBROOK, Bulletin JR 8016, 1968) Even when using a fresh solution of 2 percent buffered glutaraldehyde, the time needed at room temperature to achieve complete sterilization of Bacillus subtilis with the AOAC Pennycylinder method is said to be comprised between 3 and 10 hours according to spore dryness. I
The impossibility to store the sporicidal solution over extended periods of time, the need to buffer each time before use and the long contact time required (several hours) to achieve sterility made me develop the method and new sporicidal composition objects of th present invention.
As hereabove stated, Alkalanized Glutaraldehyde has been widely used as a chemical sterilizing agent since its antimicrobial characteristics were first described in the U.S. Pat. No. 3,016,328 (1962). R. E. Pepper and E. R. Lieberman were the first to point out in the above-mentioned patent that aqueous glutaraldehyde solutions were mildly acid and in this state they stressed that they did not exhibit sporicidal characteristics. Only when the solution was buffered by suitable alkalinating agents to a pH of 7.5 to 8.5, did the solution become antimicrobially active. (see American Journal of Hospital Pharmacy 20: 458-465, Sept. 1963). This point was emphasized in the U.S. Pat. No. 3,016,328 (1962) which stated (page 1, column 2, line 34) that the invention resided in the discovery that a saturated dialdehyde containing 2 to 6 carbon does, in fact, have sporicidal activity when it is combined with a lower alkanol and an alkalinating agent.
More recently G. Sierra in Canada (Canadian Pat. No. 865,913, March 1971) showed that the conclusions of R. E. Pepper and E. R. Lieberman were only valid in the temperature range (2223C) indicated by these authors in their U.S. patent. The Sierras Canadian patent indicates that strong sporicidal activity is exhibited by acid non-buffered non-alkalinized glutaraldehyde solutions when operating at temperatures higher (generally around 45C) than those mentioned in R. E. Peppers patent. This observation was confirmed in my own experiments. Moreover, I found, and this is one of the objects of the present invention, that with the proper combination of acid glutaraldehyde with certain nonionic or anionic surfactants at temperatures greater than 15C but specially above-45C higher sporicidal activities than those mentioned inG. Sierras patent can be achieved.
An increase in bactericidal and sporicidal activity through the combined use of glutaraldehyde (both acid and alkaline) with surfactants had been previously disclosed by A. A. Stonehill in U.S. Pat. No. 3,282,775 (November 1966). This inventor, however, referred only to the use of cationic agents. Several examples were given in the A. A. Stonehills patent. They all pertained to chemical compositions'using glutaraldehyde solutions with quaternary ammonium salts or cetylpyridinum chloride both of which exhibited sporicidal characteristics at room temperature within the 4 to 9 pH range.
It is an object of the present invention to show that a glutaraldehyde solution combined with nonionic or anionic agents such as ethoxylates of isomeric linear alcohols or alkyl aryl sulfonates is far more active than any other previously known sporicidal formula based upon the mixing of glutaraldehyde with cationic agents.
It is a further object of the present invention to show that the combined use of glutaraldehyde solutions with nonionic or anionic surfactants is effective over a wider pH range (1 to 9) while also working at any temperature inside the 15C to C range.
It is a further object of this invention to show that one can considerably reduce the sterilization time through simultaneous sonic or ultrasonic irradiation of the sporicidal compositions based upon a mixture of glutaraldehyde with nonionic orv anionic surfactants.
To aid in the understanding of my invention I shall briefly review the various physical or chemical mechanisms which play a role in the strong sporicidal effects observed in the method object of the present invention.
A few bacteria have evolved a highly effective mechanism for ensuring their survival; they exhibit an elementary form of differentiation in which, under certain conditions, the relatively sensitive vegetative form of the organism can give rise to a resistant dormant form, called a spore. Bacterial spores are much more resistant to adverse effects of heat, radiation and chemicals than their corresponding vegetative cells. The resistance of spores differs within the microbial population and species variation is common. Among the spores which were used to evaluate the methods object of the present invention 1 shall mention Bacillus subtilis, Bacillus stea'rothermopilus, Bacillus pumilus, Clostridium sporogenes and Clostridium tetani.
A bacterial spore is typically about one micro diameter and consists essentially of a small cell, often called the core or spore protoplast, surrounded by a number of specialized layers. The principal layers are the thick cortex and the multilayered coats and, around spores of certain species, a further loose and thin layer called exosporium.
At the moment it is believed (C. S. Phillips, Bact. Rev. 1962) that alkylating agents such as ethylene oxide, B propiolactone, formaldehyde, glutaraldehyde as well as other aldehydes attack the sulfhydryl (SH), hydroxyl (OH), amino (NH and carboxy groups present in spore cell proteins. More recently T. J. Munton and A. D. Russell (J. Appl. Bact., 1970) stated that the chemical sites for glutaraldehyde action could involve NH groups, including cross linking reactions between these groups (D. Hopwood, Histochemie, 1968). According to these authors, however, the suggested mechanism does not exclude sites of action with other chemical groups.
T. J. Munton and A. D. Russell (J. Appl. Bact, 1970) also showed that the uptake of acid glutaraldehyde and alkaline glutaraldehyde (sodium bicarbonate buffer) is similar and that both are of the Langmuirian type. This was demonstrated with E. Coli and Bacillus megatorium. In other words as more sites of the bacterial cell or spores are filled, glutaraldehyde molecules find increasing difficulty in attaching themselves to the cell or spore. In the methods object of the present invention it is believed that the nonionic linear alcohol ethoxylates decrease the surface tension and increase the wettability at the spore/liquid interface in such a manner that they promote a faster absorbtion rate of glutaraldehyde molecules. This could also be the result of the entraping at the spore/liquid interface of a higher concentration of glutaraldehyde molecules, said phenomenom being increased in a logarithmic manner with temperatures inside the 1575C range. Although of a lower magnitude the same increased rate of absorbtion at the spore/liquid interface is observed with anionic alkyl aryl sulfonates mixed with nonionic polyoxethylene alcohol ethers.
When speaking of absorbtion rates, one must point out that the increased wettability observed with the sporicidal molecules could be due not only to an increase at the external spore interface but also to a faster penetration inside the internal spore interfaces, i.e., across cortex layers, cortex or plasma membrane.
If using one of the sporicidal compositions object of the present invention in combination with ultrasonic irradiation extremely high killing rates are observed. This indeed could be explained in the following manner. As well known, the major component of a spore cortex layer is a polymer called murein (or peptidoglycan). Murein is present, in lesser amounts, in the walls of all bacteria. It is a large, cross-linked, net-like molecule exhibiting several unusual features. This polymer is acidic, and in spores may exist as a layer tightly contracted by some positively charged molecules. One recent theory to account for the extreme heat resistance of spores supposes that contractile pressure exerted by this structure may squeeze the central core sufficiently to maintain it in a state so dry as to confer heat resistance. Ultrasonic irradiation is one of the most efficient techniques (KY Sergeeva, Sov. Phys. Acoust., March 1966) to shake up polymer lattices and produce a fast depolymerization. This technique is said to be quite efficient over a wide frequency range both at low (G. Schmid, et al., Kolloid L, 1951) and high frequency (M. A. K. Mostafa, J. Polym. Sci. 1958). it is therefore understandable that murein depolymerization or a partial destruction of the tight cross-linked lattice would enable the aldehyde groups to penetrate and combine faster with the active spore sites. Nonionic and anionic surfactants will indeed accelerate the penetration through the loosened polymer lattice. High intensity ultrasonic energy could also play an important role through other secondary but important mechanisms.
The proteinaceous outer coats of spores contain a disulphide-rich protein with some properties close to those of keratins. Since keratin-like proteins are typically strong, inert towards chemical reagents and resistant to enzymes they constitute an ideal protective barrier for spores. High intensity ultrasonics, however, could physically degrade keratin (J. H. Bradbury, Nature, 1960) and thus promote a faster penetration of active glutaraldehyde molecules.
Two more components characteristic of spores are high levels of calcium (often 2 percent of the spores dry weight) and dipicolinic acid (DPA) which may account for over 10 percent of a spores dry weight. Under acoustic turbulence ion exchange (Ca depletion) can take place while the heterocyclic DPA molecule could also be broken (I. E. Elpiner and A. V. Sokolskaya, Sov. Phys. Acoust. March 1963). In short, ultrasonic energy could either accelerate the physical diffusion of molecules or active radicals to reaction sites inside the spores, produce chemical bond breakages of critical spore components (including site modification) or both. It could also, especially with alkaline glutaraldehyde, depolymerize some of the glutaraldehyde in solution. This could be of particular significance when one remembers that alkalinized glutaraldehyde gradually loses its activity when polymerization progresses. (A. A. Stonehill et al., Am. Journ. Hosp. Phar. 1963).
Although the synergistic sporicidal effect due to a combination of moderate heat, glutaraldehyde solution and high intensity ultrasonics has been described already in G. Sierras patent (Canadian patent application No. 98,416, 1971), the present invention shows N that an addition of nonionic or anionic surfactants to the glutaraldehyde solution leads in all cases to a substantial increase in bacteria, virus or spore killing rats.
Having described our sterilization method and the sporicidal compositions to be used with it, 1 shall now give several examples to further illustrate the invention. They are given primarily for the purposes of illustration and should not be construed as limiting theinvention to the details given.
EXAMPLES A novel aqueous bactericidal, virucidal and sporicidal composition of the present invention is prepared with 2 percent glutaraldehyde (Union Carbide grade) and 0.2 percent of a nonionic surface active agent which is a mixture of ethoxylates of isomeric linear alcohols. The linear alkyl hydrophobic portion of the surfactant being a mixture of C to C linear chains. The hydrophylic portion, being a polyoxyethylene chain (9 to 13 oxyethylene groups) randomly attached to the linear aliphatic chain through an ether linkage as shown in the following formula:
The nonionic surfactant used in the formulation object of the present invention had the following characteristics: Molecular weight 728, Cloud point (1 percent aqueous solution) 90C, Pour point 17C, 100 percent solubility in water at 25C, Apparent specific gravity 20/20C; 1.023, density 8.49 lb/gal at 30C, viscosity 48 CKS at 40C, flashpoint 460F. (ASTM method D The anionic surfactant blend with nonionic polyoxethylene alcohol ethers used in the second formulation object of the present invention had the following characteristics: Specific gravity 1.02, density 8.5- lb/gal, clear liquid soluble in hot or cold water, pH comprised between 6' and 8, freezing point -10C.
The Union Carbide grade of glutaraldehyde concentrate which was used to prepare the 2 percent solution used in our tests had the following characteristics: Specific gravity 1.058 to 1.065 at- 20C, glutaraldehyde concentration 24.5 to 25.5 percent by weight, pH 2.7 to 3.7 at C, Acidity 0.2 percent by weight, maximum, calculated as acetic acid, Iron content less than 3 ppm, heavy metals content less than 2 ppm, color 12 platinum-cobalt maximum.
The spores against which the solutions have been tested were vacuum dried strains of Clostridium Sporogenes (ATCC 7955), Bacillus globigii, Bacillus pumilus, Bacillus stearolhermophilus and Bacillus Subtilis.
The latter showed the greater resistance to the sporicidal composition and for the sake of clarity 1 shall restrict myself to the presentation of data pertaining to this microorganism.
Tests were conducted in specially designed ultrasonic stainless steel tanks (Wave Energy Systems series CTG 160) with a 2 gallon capacity. One gallon of spore suspension was used in each test. The acoustic output in liquid phase could vary from 10 to watts per liter of spore suspension. The experimental irradiation frequency was either 10 kHz or 27 k'Hz ,(i '1 kHz); At high frequency (850 kHz 20 watts/liter to 5 watts/cc) the spore solution was contained in a 2 gal glass beaker which was placed in a water filled container fitted at the bottom with a submersible transducer (glazed cobalt lead zirconate titanate). During all experiments the temperature was thermostatically controlled to i 1C of the recited temperature.
As previously stated, spores of Bacillus subtilis (ATCC 6051) were used in all the reported experiments. The preparation of clean spores was accomplished with the G. Sierra and A. Bowman technique (Journ. Appl. Microbiology, 17: 372-378, 1969). The spores were pasteurized (C, 15 min) and stored at 4C as concentrated suspensions in deionized water and used within one week. The standardization of the spore suspensions was carried out as described by G. Sierra (Can. Journ. Microbiology, 13: 489-501, 1967).
Glutaraldehyde and glutaraldehyde/surfactant solutions were freshly prepared in deionized water for each experiment. Concentrated stock solution of the buffers or sodium bicarbonate were added'separately to pasteurized spore suspensions. The pH values reported here are those of a complete system after all additions and were read with a Beckman Zeromatic ll pH meter, the calibration of which was checked before each assay was run-Stirring was continuous, and the pH was read after allowing the electrode potential to stabilize.
To recover spore survivors efficiently (especially in the lower dilutions) the effects of glutaraldehyde carryover into the viable count plates was counteracted by quenching the glutaraldehyde with sodium bisulphite before plating. After the desired treatment, samples of 0.5 ml were taken to determine the numbers of surviving spores. Each sample was diluted immediately into 4.5, ml of 1 percent sodium bisulphite 0.1 percent peptone solution and allowed to stand for 10 min, after which further serial dilutions were made in 0.5 percent sodium bisulphite 0.1 percent peptone solution. Colony counts from 0.1 ml amounts of appropriate dilutions were made on 0.1 percent starch-nutrient agar; duplicate plates were incubated at 30C for 3 days. The bisulphite treatment was found neither to potentiate glutaraldehyde induced spore inactivation nor cause detectable direct inactivation of intact spores.
In a few instances it could be of interest to use as a diluent not only filtered deionized water but a lower alkanol such as methanol, ethanol, isopropanol and the like. A mixture of both could also be used and in Table IV we give the results of a test conducted with a composition comprising 60 percent isopropyl alcohol with 37.8 percent water, 2 percent glutaraldehyde and 0.2 percent nonionic surfactant. Tables I to V show some typical results of our experiments conducted with suspensions of Bacillus Subtilis (ATCC 6051 under variable conditions (glutaraldehyde concentration, different surfactants, varying temperature and pH).
TABLE I Various concentration of glutaraldehyde Initial spores count l0'lml. temperature 55C.
1% 20 with ultrasound IS with ultrasound 15 with ultrasound l 40 no ultrasound TABLE l-Continued Various concentration of glutaraldehyde Activity at various pH 5 Initial spores count l /ml. temperature 55C. Initial spores count l0lml Ultrasonic field: Frequency 27 kHz. Ultrasonic field: Frequency 27 kHz.
Intensity 20 watts/liter Intensity 20 watts/liter pH 5. Glutaraldehyde concentration 2%.
Nonionic surfactant concentration: 0.2% Glutaraldehyde Minimum time in minutes T mp r re: 55C Concentration for 100% kill I 2 30 no ultrasound Dfluem PH fi g; F862 5 30 no ultrasound km 2 10 with ultrasound and nonionic surfactant (0.2%) Deionized water 6 l0 2 20 no ultrasound but with Deionized water 8 (with buffer) l0 nonionic surfactant (0,2 7) Deionized water 10 (with buffer) l2 Water and isopropyl alcohol (667:) 6.5 10
TABLE ll TABLE V Various concentration of different synergistic surfactants Initial spores count l0lml temperature 55C Ultrasonic field; Frequency 27 kHz, Activity at various ultrasonic frequencies and intensities intensity 20 watts/liter Glutaraldehyde concentration: 2% Initial spores count l0 /ml. pH 5. Glutaraldehyde concentration 2%. nonionic or anionic surfactant concentration: 0.2% Type of surfactant Surfactant Minimum time in min. Temperature:
concentration for l00% kill P 6 nonionic 0.02% 1 Type of Ultrasonic Minimum time nonionic 0,2 10 Surfactant Frequency in min. for i i 10 in kHz Energy density 100% kill anionic 0.02 12 anionic 0.2 l l nonionic 27 20 watts/liter l0 anionic I ll 30 nonionic 27 30 watts/liter 6 cationic 0.2 15 nonionic 27 l watt/liter l8 no surfactant nonionic 10 20 watts/liter [0 (glutaraldehyde nonionic I0 30 watts/liter 6 alone) 15 nonionic 850 20 watts/liter l2 nonionic 850 5 watts/cc 4 ethoxylatcs of isomeric linear alcohols anionic 27 20 walls/liter 12 alkyl aryl sulfonatc mixed with polyoxcthylcnc alcohol ethcrs cctylpyridinium chloride The data contained in these tables clearly show the syn- TABLE 1]] ergistic effects obtained with two types of sporicidal compositions based upon nonionic and anionic surfac- Activity at various temperatures tants dissolved in glutaraldehyde. They also show that l I the teachings of the invention may be practiced within lnitial spores count 10 m Ultrasonic field: Frequency 27 kHz. the followmg parameters Intensity 20 watts/liter Glutaraldehyde concentration: from about 0.1 per- Glutaraldehyde concentration 2% cent to about 5 percent Nonionic surfactant concentrations 0.2% pH 5 Nonionic, or anionic blend with nonionic surfactant:
from about 0.1 percent to about 1 percent. Tempemure 'f Acoustic field frequency: from about 10 kHz to about 850 kHz 153C :58 5O Acoustic field energy density: from about 1 watt/liter 60 to about 5 watt/cc C 10 Diluent: water or lower alkanol O 65 C 5 Temperature: above 15C pH range: 2 to 10 Although several specific examples of the inventive 55 TABLE [V concept have been described for purposes of illustration, the invention should not be construed as limited Activity at various pH 5 thereby nor to the specific features mentioned therein except as the same may be included in the claims aplnmal spores count l0 /ml Ultrasonic field: Frequency 27 kHz, pended hereto. It IS also understood that changes, modltensity 20 Watts/met ifications, and variations may be made without depart- Glutaraldehyde concentration 2%, f h d f h Nonionic surfactant concentration: 0.2% mg Tom t e P an Scope 0 e preseljlt mventlon- Temperature: 55C The embodiments of the invention in which an exclu- Dnuem PH Minimum time in sive property or privilege lS claimed are defined as folmin. for l00% lows:
l. A method for disinfecting or sterilizing medical, Deionized water 25 H dental, surgical instruments or other ob ects in liquid Deionized water 5 10 phase at a temperature of at least 15 C comprising contacting said object with a sporicidal composition comprising from about 0.1 percent by weight to about percent by weight of glutaraldehyde and from about 0.01 percent by weight to about 1 percent by weight of a nonionic surface active agent which is a mixture of ethoxylates of isomeric linear alcohols having the following formula:
ci-l (cum CH 0 (CH2 CHZO), H
wherein n is 9 to 13 and x is 9 to 13.
2. The method of claim 1 wherein the nonionic surface active agent is partially replaced by an anionic alkyl aryl sulfonate.
3. A method of disinfecting or sterilizing a contaminated object in liquid phase at a temperature of at least 15C, comprising contacting said object with an aqueous sporicidal solution comprising from about 0.1 percent by weight to about 5 percent by weight of glutaraldehyde and from about 0.01 percent by weight to about 1 percent by weight of a nonionic surface active agent which is a mixture of ethoxylates of isomeric linear alcohols having the following formula:
wherein n is 9 to 13 and x is 9 to 13, while simultaneously subjecting said solution to sonic or ultrasonic fields having a frequency of from about 10 kHz to about 850 kHz and an acoustic energy density of about 1 watt per liter to about 5 watts per cubic centimeter inside the irradiated liquid phase.
4. The method of claim 3 wherein part of the nonionic surface active agent is replaced by an anionic alkyl aryl sulfonate.
5. The method of claim 3 wherein the pH of the aqueous solution is from 1 to 7.
6. The method of claim 3 wherein the aqueous solution is buffered by addition of alkaline salt to a pH of from 7 to 9.
7. The method of claim 3 wherein the object to be sterilized is contacted with the aqueous solution at a temperature of from 15 to C for from 1 minute to 2 hours.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2801216 *||Apr 5, 1956||Jul 30, 1957||Union Carbide & Carbon Corp||Treatment of water with dialdehyde bactericides|
|US3016328 *||Jan 3, 1961||Jan 9, 1962||Ethicon Inc||Dialdehyde alcoholic sporicidal composition|
|US3057775 *||Feb 4, 1959||Oct 9, 1962||Champion Co||Embalming composition|
|US3282775 *||May 10, 1963||Nov 1, 1966||Ethicon Inc||Sporicidal compositions comprising a saturated dialdehyde and a cationic surfactant|
|US3481687 *||Mar 8, 1965||Dec 2, 1969||Fishman Sherman S||Method and apparatus for ultrasonic sterilization|
|US3497590 *||Aug 24, 1967||Feb 24, 1970||Colgate Palmolive Co||Oral compositions containing non-toxic,non-volatile aliphatic aldehyde|
|US3697222 *||Aug 3, 1970||Oct 10, 1972||Ontario Research Foundation||Sterilization with glutaraldehyde|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4048336 *||Apr 23, 1975||Sep 13, 1977||West Chemical Products, Incorporated||Means for killing bacterial spores with glutaraldehyde sporicidal compositions|
|US4084747 *||Mar 26, 1976||Apr 18, 1978||Howard Alliger||Germ killing composition and method|
|US4093744 *||Jul 17, 1975||Jun 6, 1978||West Laboratories, Inc.||Killing bacterial spores with glutaraldehyde sporicidal compositions|
|US4103001 *||Aug 30, 1976||Jul 25, 1978||Schattner Robert I||Buffered phenol-glutaraldehyde sterilizing compositions|
|US4208404 *||Oct 23, 1978||Jun 17, 1980||Cowan Stanley M||Glutaraldehyde sterilizing compositions|
|US4211744 *||May 24, 1978||Jul 8, 1980||Biophysics Research & Consulting Corporation||Process for ultrasonic pasteurization|
|US4294797 *||Apr 18, 1980||Oct 13, 1981||Kaltenbach & Voight Gmbh & Co.||Servicing composition for spraying on medical instruments|
|US4308229 *||Sep 4, 1980||Dec 29, 1981||Voit J Kenneth||Sterilization apparatus and method|
|US4381314 *||Nov 21, 1980||Apr 26, 1983||Bausch & Lomb Incorporated||Contact lens disinfecting and preserving solution|
|US4389490 *||May 29, 1981||Jun 21, 1983||Coulter Electronics, Inc.||Method of stabilizing platelets for determining multiple platelet parameters in reference control and calibrator compositions; and diluents thereof|
|US4444785 *||Jan 19, 1983||Apr 24, 1984||Bausch & Lomb Incorporated||Contact lens disinfecting and preserving solution|
|US4448750 *||May 23, 1983||May 15, 1984||Fuesting Michael L||Sterilization method|
|US4592892 *||Nov 8, 1982||Jun 3, 1986||Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo||Aqueous sterilizing agent for foods or food processing machines and utensils|
|US4607652 *||Nov 29, 1984||Aug 26, 1986||Yung Simon K C||Contact lens cleaning apparatus|
|US4690772 *||Jun 3, 1985||Sep 1, 1987||National Medical Care||Sterilant compositions|
|US4697605 *||Jun 2, 1986||Oct 6, 1987||Smc Metal Tech Co., Ltd.||Contact lens cleaning apparatus|
|US4847304 *||May 21, 1987||Jul 11, 1989||Surgikos, Inc.||Disinfecting and sterilizing composition|
|US4851449 *||May 21, 1987||Jul 25, 1989||Surgikos, Inc.||Odorless aromatic dialdehyde disinfecting and sterilizing composition|
|US4971999 *||May 10, 1989||Nov 20, 1990||Johnson & Johnson Medical, Inc.||Odorless aromatic dialdehyde disinfecting and sterilizing composition and method of using the same|
|US4978530 *||Feb 25, 1987||Dec 18, 1990||Health Care Products, Inc.||Sanitized, disinfected and sporicidal articles, and processes for sanitizing, disinfecting and rendering objects sporicidal|
|US5008023 *||Aug 13, 1990||Apr 16, 1991||Betz Laboratories, Inc.||Biocidal compositions and use thereof containing a synergistic mixture of glutaraldehyde and 2-(decylthio) enthanamine|
|US5190724 *||Sep 11, 1989||Mar 2, 1993||Henkel Kommanditgesellschaft Auf Aktien||Process for disinfecting medical molding materials|
|US5250573 *||Nov 9, 1988||Oct 5, 1993||Germo S.P.A.||Glutaraldehyde-based sterilising composition of antibacterial and antimycotic activity, in an aqueous vehicle|
|US5401625 *||Jun 24, 1993||Mar 28, 1995||E. K. Industries, Inc.||Histological composition for light microscopy|
|US5422068 *||Jan 5, 1994||Jun 6, 1995||Shalaby; Shalaby W.||Radiochemical sterilization|
|US5447684 *||Dec 6, 1993||Sep 5, 1995||Williams; Robert M.||Sterilization devices, sporicidal compositions, sterilization methods, and devices for reducing surface tension|
|US5674829 *||Jan 24, 1996||Oct 7, 1997||Antoinetta P. Martin||Stable aqueous glutaraldehyde solutions containing sodium acetate and a nonionic detergent|
|US5736100 *||Sep 19, 1995||Apr 7, 1998||Hitachi, Ltd.||Chemical analyzer non-invasive stirrer|
|US5783146 *||Sep 5, 1996||Jul 21, 1998||Williams, Jr.; Robert M.||Sporicidal compositions, sterlization devices and methods for rapid cleaning, disinfection, and sterilization|
|US6379685 *||Sep 24, 1998||Apr 30, 2002||Ecolab Inc.||Acidic aqueous chlorite teat dip with improved emollient providing shelf life, sanitizing capacity and tissue protection|
|US6387858 *||Mar 31, 2000||May 14, 2002||Steris Inc.||Safe transport gel for treating medical instruments|
|US6436444||Sep 26, 1997||Aug 20, 2002||Ecolab Inc.||Acidic aqueous chlorite teat dip providing shelf life sanitizing capacity and tissue protection|
|US6632397||Sep 30, 1999||Oct 14, 2003||Minntech Corporation||Multi-part anti-microbial concentrate system, activated solution, use-dilution solution, method of making same, and method of sterilizing with the use-dilution solution|
|US6699510||Aug 19, 2002||Mar 2, 2004||Ecolab Inc.||Acidic aqueous chlorite teat dip with improved visual indicator stability, extended shelf life, sanitizing capacity and tissue protection|
|US6749869||Sep 26, 1997||Jun 15, 2004||Ecolab||Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection|
|US6891069||Jan 30, 2004||May 10, 2005||Ethicon, Inc.||Synthesis of 4-substituted phthalaldehyde|
|US7291649||Jun 29, 2005||Nov 6, 2007||Ethicon, Inc.||Forming germicidal aromatic dialdehydes with acetals|
|US7390837||Jan 30, 2004||Jun 24, 2008||Ethicon, Inc.||Germicidal compositions containing phenylmalonaldehyde-type compounds, or mixtures of phenylmalonaldehyde-type compounds and phthalaldehydes, and methods of using such compositions for disinfection or sterilization|
|US7476767||Jan 30, 2004||Jan 13, 2009||Ethicon, Inc.||Alpha-hydroxy sulfonate aldehydes, germicidal compositions containing the alpha-hydroxy sulfonate aldehydes, or mixtures of alpha-hydroxy sulfonate aldehydes and phthalaldehydes, and methods of using the compounds or compositions for disinfection or sterilization|
|US7939501||Apr 15, 2004||May 10, 2011||Smith Francis X||Ophthalmic and contact lens solutions containing peptides as preservative|
|US8247461||Jan 26, 2010||Aug 21, 2012||Smith Francis X||Ophthalmic and contact lens solution|
|US8257909 *||Aug 26, 2003||Sep 4, 2012||Fujitsu Semiconductor Limited||Method of manufacturing semiconductor device, and method of forming resist pattern|
|US8338080 *||Nov 25, 2003||Dec 25, 2012||Fujitsu Limited||Process for forming resist pattern, semiconductor device and fabrication thereof|
|US8557868||Nov 14, 2002||Oct 15, 2013||Fxs Ventures, Llc||Ophthalmic and contact lens solutions using low molecular weight amines|
|US8729135||Mar 13, 2009||May 20, 2014||Antonietta Pamela Martin||Glutaraldehyde composition|
|US9308264||Nov 16, 2012||Apr 12, 2016||Fxs Ventures, Llc||Ophthalmic contact lens solutions containing forms of vitamin B|
|US20030190258 *||Nov 14, 2002||Oct 9, 2003||Smith Francis X.||Ophthalmic and contact lens solutions using low molecular weight amines|
|US20040043332 *||Aug 26, 2003||Mar 4, 2004||Fujitsu Limited||Method of manufacturing semiconductor device, and method of forming resist pattern|
|US20040110099 *||Nov 25, 2003||Jun 10, 2004||Fujitsu Limited||Process for forming resist pattern, semiconductor device and fabrication thereof|
|US20040242702 *||Jul 26, 2002||Dec 2, 2004||Martin Antonietta Pamela||Glutaraldehyde composition|
|US20050042198 *||May 10, 2004||Feb 24, 2005||Smith Francis X.||Ophthalmic and contact lens wetting solutions|
|US20050136086 *||Dec 19, 2003||Jun 23, 2005||Rafael Herruzo||Efficacy enhancers for germicides|
|US20050136118 *||Dec 19, 2003||Jun 23, 2005||Wu Su-Syin S.||Distribution and preparation of germicidal compositions|
|US20050171121 *||Jan 30, 2004||Aug 4, 2005||Zhu Peter C.||Germicidal compositions containing phenylmalonaldehyde-type compounds, or mixtures of phenylmalonaldehyde-type compounds and phthalaldehydes, and methods of using such compositions for disinfection or sterilization|
|US20050171201 *||Jan 30, 2004||Aug 4, 2005||Zhu Peter C.||Alpha-hydroxy sulfonate aldehydes, germicidal compositions containing the alpha-hydroxy sulfonate aldehydes, or mixtures of alpha-hydroxy sulfonate aldehydes and phthalaldehydes, and methods of using the compounds or compositions for disinfection or sterilization|
|US20050171215 *||Jan 30, 2004||Aug 4, 2005||Ethicon, Inc.||Germicidal compositions containing halogenated phthalaldehyes, and methods of using such compositions for disinfection or sterilization|
|US20050171216 *||Jan 30, 2004||Aug 4, 2005||Zhu Peter C.||Germicidal compositions containing phthalaldehyde mixtures and methods of using such compositions for disinfection or sterilization|
|US20050238732 *||Nov 30, 2004||Oct 27, 2005||Kaitao Lu||Carbonated germicide with pressure control|
|US20060078626 *||Nov 8, 2001||Apr 13, 2006||Bioconcept Laboratories||Opthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative|
|US20060142169 *||Nov 8, 2001||Jun 29, 2006||Bioconcept Laboratories||Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers|
|US20060148665 *||Nov 8, 2001||Jul 6, 2006||Bioconcept Laboratories||Ophthalmic and contact lens solutions containing forms of vitamin b|
|US20070004808 *||Jun 29, 2005||Jan 4, 2007||Zhu Peter C||Forming germicidal aromatic dialdehydes with acetals|
|US20070098813 *||Dec 19, 2006||May 3, 2007||Fxs Ventures, Llc||Ophthalmic and contact lens solutions with a peroxide source and a preservative|
|US20070098818 *||Dec 19, 2006||May 3, 2007||Fxs Ventures, Llc||Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers|
|US20070104744 *||Jan 5, 2007||May 10, 2007||Fxs Ventures, Llc||Ophthalmic and contact lens solutions containing forms of vitamin b|
|US20080167246 *||Apr 15, 2004||Jul 10, 2008||Bioconcept Laboratories||Ophthalmic and Contact Lens Solutions Containing Peptides as Preservative|
|US20090227684 *||Mar 13, 2009||Sep 10, 2009||Antonietta Pamela Martin||Glutaraldehyde composition|
|US20100122918 *||Jan 26, 2010||May 20, 2010||Smith Francis X||Ophthalmic and contact lens solution|
|US20110212885 *||Sep 1, 2011||Smith Francis X||Ophthalmic and contact lens solutions containing peptides as preservative|
|USRE31779 *||Apr 17, 1980||Dec 25, 1984||Alcide Corporation||Germ-killing composition and method|
|USRE41279||Mar 2, 2006||Apr 27, 2010||Ecolab Inc.||Acidic aqueous chlorite teat dip with improved visual indicator stability, extended shelf life, sanitizing capacity and tissue protection|
|DE19626872B4 *||Jul 4, 1996||Jan 27, 2005||Miele & Cie. Kg||Spülverfahren für medizinische oder chirurgische Instrumente in einem programmgesteuerten Spülautomaten und Reiniger für das Verfahren|
|EP0255875A1 *||Jul 8, 1987||Feb 17, 1988||Germo S.P.A.||Glutaraldehyde-based sterilising composition of antibacterial and antimycotic activity in an aqueous vehicle|
|EP0360118A1 *||Sep 11, 1989||Mar 28, 1990||Henkel Kommanditgesellschaft auf Aktien||Method of disinfecting medical impressions|
|EP0609106A1 *||Jan 31, 1994||Aug 3, 1994||Toni Martin Marketing And Distributors Cc||A glutaraldehyde composition|
|EP2796543A4 *||Dec 20, 2012||Aug 5, 2015||Cj Cheiljedang Corp||Method for sterilizing microbial cells using polyethylene glycol-based nonionic surfactant|
|WO1984001894A1 *||Nov 3, 1983||May 24, 1984||American Hospital Supply Corp||Chemical sterilization of implantable biological tissue|
|WO1990003191A1 *||Sep 11, 1989||Apr 5, 1990||Henkel Kommanditgesellschaft Auf Aktien||Process for disinfecting medical casting materials|
|WO1991016083A1 *||Apr 16, 1991||Oct 31, 1991||Wave Energy Systems, Inc.||Stable antimicrobial glutaraldehyde system|
|WO1992010935A1 *||Dec 17, 1991||Jul 9, 1992||Glaxo S.P.A.||Sterilising composition|
|WO1994013138A1 *||Dec 15, 1993||Jun 23, 1994||Williams Robert M||Sterilization devices, sporidical compositions, sterilization methods, and devices for reducing surface tension|
|WO2003011027A1 *||Jul 26, 2002||Feb 13, 2003||Antonietta Pamela Martin||A glutaraldehyde composition|
|U.S. Classification||422/20, 422/36, 514/705|
|International Classification||A01N35/02, A61L2/025, C11D3/20, C11D3/48, A61L2/00, C11D1/72, C11D11/00|
|Cooperative Classification||C11D3/2072, C11D3/48, A61L2/025, C11D11/007, C11D1/72, A01N35/02, A61L2/00|
|European Classification||C11D3/48, C11D3/20D, A01N35/02, C11D11/00B10, C11D1/72, A61L2/025, A61L2/00|